Selected article for: "disease affect and immune system"

Author: Tagde, Priti; Tagde, Sandeep; Tagde, Pooja; Bhattacharya, Tanima; Monzur, Shams Minhaz; Rahman, Md. Habibur; Otrisal, Pavel; Behl, Tapan; ul Hassan, Syed Shams; Abdel-Daim, Mohamed M.; Aleya, Lotfi; Bungau, Simona
Title: Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2
  • Cord-id: m8vift11
  • Document date: 2021_9_18
  • ID: m8vift11
    Snippet: The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or sign
    Document: The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these “cures” that can provide real revelations in the therapy of coronavirus infection

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute respiratory infection: 1, 2, 3, 4
    • ace inhibitor and lung disease: 1
    • active site and acute ards respiratory distress syndrome: 1, 2
    • active site and acute respiratory infection: 1, 2, 3, 4, 5, 6
    • active site and adaptive strategy: 1
    • active site and low bioavailability: 1, 2, 3
    • active site and lung disease: 1
    • acute ards respiratory distress syndrome and adenine dinucleotide phosphate: 1
    • acute ards respiratory distress syndrome and adenosine triphosphatase: 1
    • acute ards respiratory distress syndrome and adjuvant benefit: 1
    • acute ards respiratory distress syndrome and administration mode: 1
    • acute ards respiratory distress syndrome and long term effect: 1
    • acute ards respiratory distress syndrome and low airway: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute ards respiratory distress syndrome and lung viral load: 1, 2, 3
    • acute ards respiratory distress syndrome and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7
    • acute inflammation and adenine dinucleotide phosphate: 1
    • acute inflammation and lupus erythematosus: 1, 2